retatrutide phase 2 trial obesity nejm 2023 on X: "This week's most cited articles: 1. Original Article: Triple–Hormone-Receptor Agonist for — A https://t.co/jNL1GNnHPT #Endocrinology https://t.co/ZknpCo49ky" / X retatrutide phase 2 nejm 2023

Phytochemistry , 113532

Other licensed pharmacological options : For patients unsuitable for or unable to tolerate Wegovy, alternatives include: Orlistat (lipase inhibitor that reduces fat absorption) Liraglutide 3mg (another GLP-1 receptor agonist, recommended by NICE TA664 for specific patient groups, though local NHS availability may vary) Consideration of bariatric surgery referral for eligible patients with severe obesity Medically supervised diets : If rapid weight loss is clinically indicated (e.g., pre-bariatric surgery), options include: Very low-calorie diets (800 kcal/day) under specialist supervision for up to 12 weeks Low-calorie diets (8001200 kcal/day) with appropriate nutritional support These differ fundamentally from HCG protocols as they provide adequate protein, vitamins, and minerals and are used within NHS-approved frameworks

So, if it's going down, let's just give it back

Step 2: Pick your "anchor" time

doi: 10.3233/JAD-130491 230 SpolcovaAMikulaskovaBHolubovaMNagelovaVPirnikZZemenovaJet al